Takuma Fujii
Overview
Explore the profile of Takuma Fujii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
750
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torii Y, Naito K, Takagi J, Yasue A, Tsukada K, Fujii T, et al.
Fujita Med J
. 2025 Feb;
11(1):11-19.
PMID: 39896227
Objectives: Chemotherapy-induced peripheral neuropathy (CIPN), a frequently occurring adverse event associated with paclitaxel/carboplatin (TC) combination therapy, causes limb pain and markedly reduces the patient's quality of life. Since zinc has...
2.
Mikami M, Tanabe K, Imanishi T, Ikeda M, Hirasawa T, Yasaka M, et al.
Sci Rep
. 2024 Aug;
14(1):20000.
PMID: 39198565
Epithelial ovarian cancer (EOC) is widely recognized as the most lethal gynecological malignancy; however, its early-stage detection remains a considerable clinical challenge. To address this, we have introduced a new...
3.
Nishibe-Toyosato S, Ando Y, Torii Y, Ichikawa R, Owaki A, Miyamura H, et al.
In Vivo
. 2024 Aug;
38(5):2374-2382.
PMID: 39187311
Background/aim: The frequency rate of injection site reactions (ISR) due to fosaprepitant meglumine (Fos APR) has been shown to vary depending on the types of combined anticancer drug. This study...
4.
Kawasaki R, Kukimoto I, Tsukamoto T, Nishio E, Iwata A, Fujii T
Cancer Sci
. 2024 Aug;
115(11):3672-3681.
PMID: 39171738
Approximately 660,000 women are diagnosed with cervical cancer annually. Current screening options such as cytology or human papillomavirus testing have limitations, creating a need to identify more effective ancillary biomarkers...
5.
Fujii T, Nishio E, Tsukamoto T, Kukimoto I, Iwata A
Cancer Sci
. 2024 May;
115(8):2795-2807.
PMID: 38749770
Currently, human papillomavirus tests and cytology are used to screen for cervical cancer. However, more accurate ancillary screening tests are needed. MicroRNAs (miRNAs) and cytokines are promising biomarkers that are...
6.
Nishio E, Ishitani K, Arimoto T, Igarashi T, Ishikawa T, Iwase A, et al.
J Obstet Gynaecol Res
. 2024 Apr;
50(7):1073-1094.
PMID: 38627197
Twelve years after the first edition of The Guideline for Gynecological Practice, which was jointly edited by The Japan Society of Obstetrics and Gynecology and The Japan Association of Obstetricians...
7.
Nishio E, Iwata A, Kawasaki R, Iwao K, Nishizawa H, Fujii T
Reprod Med Biol
. 2024 Mar;
23(1):e12568.
PMID: 38476960
Purpose: In the context of in vitro fertilization-embryo transfer (IVF-ET), factors other than egg quality may be key determinants of treatment success, in particular, maternal factors related to uterine endometrial...
8.
Yoshida H, Matsuo K, Machida H, Matsuzaki S, Maeda M, Terai Y, et al.
Int J Gynecol Cancer
. 2024 Feb;
34(4):510-518.
PMID: 38316444
Objective: To examine the association between intrauterine manipulator use and pathological factors and oncologic outcomes in patients with endometrial cancer who had laparoscopic hysterectomy in Japan. Methods: This was a...
9.
Mitani T, Kukimoto I, Tsukamoto T, Nomura H, Fujii T
Sci Rep
. 2024 Feb;
14(1):2632.
PMID: 38302551
Approximately 500,000 women are diagnosed with cervical cancer annually, with high-grade cervical intraepithelial neoplasia (CIN) estimated to be 20 times higher. The diathermy ablation is an inexpensive minimally invasive surgeries...
10.
Onuki M, Takahashi F, Iwata T, Nakazawa H, Yahata H, Kanao H, et al.
Cancer Sci
. 2023 Sep;
114(11):4426-4432.
PMID: 37688310
The first prophylactic vaccine against human papillomavirus (HPV) 16 and HPV18 was licensed in Japan in 2009. HPV vaccine effectiveness against high-grade cervical lesions has been demonstrated among young Japanese...